GSDME and lung cancer: Meanwhile, it is reported that the increased level of GSDME activated by caspase-3 with chemotherapeutic drugs such as cisplatin and paclitaxel leads to the switch from apoptosis to pyroptosis in lung cancer cells [49, 87].